State pharmacy regulators on at least two occasions in the past decade displayed indifference in their oversight of a troubled Framingham specialty pharmacy that has now been blamed for a national fungal meningitis outbreak, according to documents obtained by the Globe Tuesday. While state and federal regulators were investigating New England Compounding Center for problems with sterile drug preparation, the company’s lead pharmacist was chosen to serve on a state pharmacy board task force to write new rules for compounding pharmacies.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help